Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Serina Therapeutics (SER)
NYSE MKT:SER
Serina Therapeutics (SER) Stock Price & Analysis
179 Followers
SER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.17 - $31.66
Previous Close$7.17
Volume9.51K
Average Volume (3M)16.79K
Market Cap
$59.99M
Enterprise Value$64.24M
Total Cash (Recent Filing)$345.00K
Total Debt (Recent Filing)$4.37M
Price to Earnings (P/E)―
Beta-0.29
Next Earnings
Aug 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.06
Shares Outstanding8,413,889
10 Day Avg. Volume26,592
30 Day Avg. Volume16,791
Standard Deviation0.25
R-Squared0.06
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)14.26
Price to Sales (P/S)488.24
Price to Cash Flow (P/CF)-8.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue773.93
Enterprise Value/Gross Profit629.77
Enterprise Value/Ebitda-34.41
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Serina Therapeutics News
PremiumCompany Announcements
Serina Therapeutics: Strategic Restructuring and Merger Success
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SER FAQ
What was Serina Therapeutics’s price range in the past 12 months?
Serina Therapeutics lowest stock price was $7.17 and its highest was $31.66 in the past 12 months.
What is Serina Therapeutics’s market cap?
Currently, no data Available
When is Serina Therapeutics’s upcoming earnings report date?
Serina Therapeutics’s upcoming earnings report date is Aug 14, 2024 which is in 37 days.
How were Serina Therapeutics’s earnings last quarter?
Serina Therapeutics released its earnings results on May 14, 2024. The company reported -$3.382 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.382.
Is Serina Therapeutics overvalued?
According to Wall Street analysts Serina Therapeutics’s price is currently Overvalued.
Does Serina Therapeutics pay dividends?
Serina Therapeutics does not currently pay dividends.
What is Serina Therapeutics’s EPS estimate?
Serina Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Serina Therapeutics have?
Serina Therapeutics has 8,413,889 shares outstanding.
What happened to Serina Therapeutics’s price movement after its last earnings report?
Serina Therapeutics reported an EPS of -$3.382 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.437%.
Which hedge fund is a major shareholder of Serina Therapeutics?
Among the largest hedge funds holding Serina Therapeutics’s share is Defender Capital, LLC.. It holds Serina Therapeutics’s shares valued at N/A.
---
Serina Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 969.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $383.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-72.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.37%
Trailing 12-Months
Company Description
Serina Therapeutics
AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
---
Technical Analysis
Arrowhead Pharmaceuticals
―
Ardelyx
―
Crispr Therapeutics AG
―
Sarepta Therapeutics
―
Alimera
―
---